locations contact us r & d pipeline technology dry powder formulation inhalation profiling oral inhalers publications patent notices partnering investors overview stock information historical price lookup investment calculator ownership profile investors faqs sec filings analyst coverage financial information annual reports quarterly results key ratios corporate governance management board of directors documents & charters committee composition contact the board request materials news & events press releases events webcasts careers overview job search total rewards home contact us 661 775 5300 afrezza.com about us our values products board of directors corporate governance executive management committee composition alfred e. mann locations contact us r & d pipeline technology dry powder formulation inhalation profiling oral inhalers publications patent notices partnering investors overview stock information historical price lookup investment calculator ownership profile investors faqs sec filings analyst coverage financial information annual reports quarterly results key ratios corporate governance management board of directors documents & charters committee composition contact the board request materials news & events press releases events webcasts careers overview job search total rewards our focus is patients our passion is innovation mannkind corporation develops patient focused drug therapies and innovative technology solutions . more advanced science practical design we specialize in innovative technologies with proven ease of use and patient acceptance . more patient friendly inhalation treatments needle free self administered inhalation treatment systems for both chronic and acute diseases . more in partnership your drug our delivery . our technosphere technology can accommodate a wide variety of apis required by specific drug therapies . more about us mannkind corporation nasdaq and tase mnkd is a biopharmaceutical company that focuses on the discovery development and commercialization of therapeutic products for patients with diseases such as diabetes . more investor faq august 2016 click here fda approved for information about afrezza please visit www.afrezza.com . news & events sep 02 2016 mannkind corporation to present at the rodman & renshaw 18th annual global investment conference more aug 25 2016 securities class action against mannkind dismissed more aug 08 2016 mannkind corporation reports 2016 second quarter financial results more mannkind corporation 2010 2016 all rights reserved privacy policy sitemap terms of use twitter facebook